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Chromogranin A (CGA) is an abundant protein of dense- 
cored secretory vesicles in endocrine and neuronal cells. The 
present study, for the first time, compares CGA of neurons 
of the central nervous system with the CGA of adrenal ori- 
gin. By S1 nucleus protection assay, we found that the 3' 
part of the CGA mRNA between exons 5-8 of the cerebel- 
lum and the spinal cord of the rat is homologous to that 
of the adrenal. In situ hybridization histochemistry revealed 
that CGA mRNA in the cerebellar cortex is present in cell 
bodies of Purkinje cells and in neurons of the deep cerebel- 
lar nuclei. The perikarya of these cells also exhibit CGA-like 
immunoreactivity. CGA mRNA and CGA-like immunoreac- 
Introduction 
Chromogranin A (CGA) is a member of the chromograninkecre- 
togranin protein family. This acidic protein was found first in chro- 
maffin vesicles of the adrenal medullary cells, where it is stored 
and co-released with catecholamines (1,3). Various studies have in- 
dicated that CGA is not restricted to the adrenal medulla but is 
also found in a variety of peptidergic endocrine cells (cf. 
8,9,17,24,31,42). 
CGA binds calcium (4,27,29,30). There is evidence that the 
CGA-calcium complex participates in the intracellular storage of 
catecholamines and polypeptide hormones (12,13,39,41). CGA it- 
self, or proteolytic fragments of CGA, has been shown to inhibit 
secretion by various endocrine cells such as adrenal chromaffin cells, 
pancreatic B-cells, and parathyroid cells (7,10,14,32), suggesting that 
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tivity are also present in the motoneurons of the ventral, 
lateral, and dorsal horns of the rat spinal cord. The amounts 
of CGA, as determined by radioimmunoassay in cerebellum 
and spinal cord, were about one tenth of the amounts de- 
tected in the adrenal, adenohypophysis, or the olfactory bulb. 
The sites of CGA expression suggest that CGA may be in- 
volved in signal transduction in the motor system. (JHisto- 
&em Cyrocbem 40:#3-999, 1992) 
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this protein plays an important function in the regulation of hoi- 
mone release by endocrine glands. 
In contrast to the endocrine system, little information is avail- 
able on the synthesis and the function of CGA in the central ner- 
vous system. Its occurrence and distribution have first been deter- 
mined with immunological techniques in ovine and bovine neural 
tissues (16,19,24,25,33). CGA was found to be widely distributed 
in brain and spinal cord without a clear-cut correlation with known 
transmitter systems (cf. 5,33) and, compared with endocrine tis- 
sues, appears to be of low abundance in the central nervous system 
(19,25,38). One exception is the olfactory system, which contains 
CGA in amounts comparable to those found in the adrenal medulla 
or the adenohypophysis (22). In the olfactory system, we have found 
that CGA is present mainly in the centrally projecting axon termi- 
nals of the secondary neurons of the olfactory system. 
Secretory proteins such as CGA, which are synthesized in the 
perikarya of neurons, are rapidly transported to their axons. There- 
fore, their detection by immunocytochemistry is often very diffi- 
cult. The recent elucidation of the complete adrenal cDNA cod- 
ing sequences of CGA of different species (c f .  17) allows the 
identification of CGA mRNA in perikarya of neurons by in situ 
hybridization histochemistry. This method complements i"u- 
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nocytochemistry. Information about  t h e  sequences of C G A  mRNA 
from different tissues can be  obtained by S1 nuclease protection 
assays. T h e  2 KB-long C G A  m R N A  of rat a n d  mouse is composed 
of eight exons. Some C G A  domains, deduced from t h e  primary 
structure, are correlated to  specific exons (40).  
Here we report t h e  gene expression of C G A  a t  protein and  
mRNA levels in  cerebellum a n d  spinal cord of the  rat, using both 
radioactive a n d  non-radioactive cRNA probes, S1 nuclease protec- 
tion assays, immunocytochemistry, a n d  radioimmunoassay. 
Materials and Methods 
Experimental Procedurej 
Animals. Adult male rats (Sprague-Dawley) were purchased from 
Charles River (Sulzfeld, FRG) and housed in our vivarium under standard 
conditions. Animals were sacrificed by decapitation and tissues were im- 
mediately removed and further processed as described below. 
Immunocytochemistry and Radioimmunoassay. Brains and segments 
of thoracic spinal cords (approximately 1 cm long) of male rats were im- 
mersed in Bouin's fixative for 12 hr. Subsequently, they were embedded 
in paraffin and serial sections were cut (5  pm) and mounted on gelatin- 
coated glass slides. For immunocytochemistry, sections of the cerebellum 
and spinal cord were selected. A rabbit antiserum directed against the 
C-terminal peptide (16-mer) of bovine CGA was used. Bovine CGA differs 
only slightly in sequence from rat CGA, and therefore this antiserum also 
recognizes rat CGA. The specificity of this antiserum (kindly provided by 
D.T. O'Connor. San Diego, CA) and its use for immunocytochemistry and 
immunoblotting of neural and endocrine tissue from rat have been de- 
scribed previously (2,22). To detect CGA immunoreactivity, we used the 
peroxidase-anti-peroxidase (PAP) method. In brief, paraffin-embedded sec- 
tions were deparaffinized, permeabilized with 0.5% Triton X-100 in Tris- 
buffered saline (TBS; 0.05 M Tris and 0.15 M NaC1, pH 7.6), and were then 
incubated in TBS containing 10% methanol and 0.03% H202 to block 
endogenous peroxidase activity. Subsequently, they were pre-incubated with 
2 %  normal swine serum (NSS) in TBS, followed by incubation with CGA 
antiserum diluted in 2% NSS in TBS. Different dilution steps of this anti- 
body were tested and a dilution of 11000 was used in all experiments reported 
here. Incubation with a second swine anti-rabbit antiserum and incuba- 
tion with a rabbit-PAP complex followed. Diaminobenzidine was used as 
a chromogen to visualize the immunoreaction. Controls consisted of incu- 
bation with 2% NSS in TBS instead of the specific antibody and of incu- 
bation with normal serum (1:1000). Sections were photographed using a 
Zeiss (Oberkochen, FRG) Axioplan microscope. 
For extraction of CGA, small pieces of tissue (about 20-200 mg) were 
rapidly frozen. After addition of 0.1 M HC1 (300-1000 pl) the tissue was 
sonicated until it was completely homogenized. After lyophilization and 
appropriate dilution, CGA was quantified by radioimmunoassay as described 
previously (26,34,37). The antisera to CGA were raised in rabbits to a syn- 
thetic peptide 17-mer corresponding to the amino terminus of bovine/hu- 
man CGA. After an overnight incubation of antibody and radiolabeled 
N-terminal CGA peptide (10,000 cpm) in assay buffer at 4 ° C  an excess 
titer of second antibody (goat anti-rabbit gamma globulin; Scantibodies, 
Lakeside, CA) was added. After vortexing, polyethylene glycol was added 
to precipitate the immune complexes (leaving the free antigen in solution). 
The solution was centrifuged at 1700 x g for 20 min. the supernatant aspi- 
rated, and the radioactivity of the pellet was subjected to gamma counting 
for 1 2 > 1  (Searle Mark IV). Immunoreactive CGA was determined by paral- 
lel displacement of CGA[l-l6]-'*'I-[tyrl7) (tracer) and unknown sample 
from the antibody in the radioimmunoassay. The assay had intra- and in- 
terassay coefficients of variation of 4.8% and 8.4%, respectively. 
cDNA and cRNA probes. For cRNA and cDNA probe synthesis we 
used a rat CGA cDNA (28) (kindly provided by R. Parmer and D.T. O'Con- 
nor, San Diego, CA) as previously described (22). A clone referred to as 
rCGA M13( - )  was used to generate cRNA and [DNA anti-sense strands 
of the CGA mRNA, originating within Exon 8 and extending towards the 
5' end. 
For S1 analysis a 950 nucleotide (nt) fragment yielded as calculated by 
the sequence map (28) was used. This cDNA probe contains 644 nt of the 
translated (Exons 5-8) and 192 nt of the untranslated 3' end from the rat 
CGA sequence and 114 nt of vector sequences and extends from Exon 6 
to Exon 8 (40). 
Synthesis of 3'S-labeled cRNA (a) (spec. act. 5 x 10' c p m / N )  for in 
situ hybridization was carried out as described by Lahr et al. (22). The T3 
promoter was used to synthesize the cRNA probe within Exon 8 280 
nucleotides in length. 
Synthesis of Dig-11-UP-labeled cRNA (b) for non-isotopic in situ hy- 
bridization was carried out according to the protocol of Boehringer (Mann- 
heim, FRG) using T3-RNA polymerase, ATP, GTP, CTP, 1 mM each and 
0.65 mM UTP and 0.35 mM Dig-11-UTP. As template we used 1 pg rCGA 
M13( -) linearized with Pvull. The resulting digoxigenin-labeled cRNA probe 
originates with Exon 8 and contains 280 nucleotides. 
Controls for the specificity of hybridization signals consisted of treat- 
ing tissues with 100 pglml RNAse A (Boehringer) in 10 mM Tris-HCI, 15 
mM NaCl (pH 7.0) for 1 hr at 37°C before hybridization. 
SI Nuclease Protection Assay 
Total RNA was isolated by a modified guanidinium thiocyanate-CsC1 
method (18) from male rat adrenals, cerebelli, and spinal cords. Twenty 
pg total RNA (determined photometrically) were hybridized with an ex- 
cess of 32P-labeled cDNA probe ( 5  x lo4 cpm; spec. act. 1 x 10' cpmlpg) 
in 75% formamide, 400 mM NaCI, 1 mM EDTA, and 20 mM Tris-HCI 
(pH 7.4), for 16 hr at 58°C. Hybridization was terminated by digestion 
with 680 U S1 nuclease (AGS; Heidelberg, FRG) for 2 hr at 37°C. After 
phenol extraction and ethanol precipitation, samples were separated elec- 
trophoretically on 0.3-mm thick 50/0 polyacrylamide gels (8.3 M urea). Gels 
were dried and exposed to X-ray film at - 70°C. using intensifying screens. 
In Situ Hybridization Histochemistry 
For isotopic in situ hybridization of the rat spinal cord, (a) tissues were im- 
mediately frozen and stored in liquid nitrogen. Cryostat sections (10 pm; 
Reichert-Jung, Nussloch, FRG) were mounted on 3-aminopropyltriethoxy- 
silan (Sigma; Munich, FRG)-coated slides. Sections were stored until needed 
at -8O'C. They were fixed in 4% paraformaldehyde/PBS for 30 min at 
room temperature. rinsed twice in PBS, and dehydrated by an ascending 
series of graded alcohol. 
For non-isotopic in situ hybridization and isotopic in situ hybridiza- 
tion of cerebellum (b) tissues were immersed in Bouin's fixative for 12 hr, 
embedded in paraffin, and serial sections were cut ( 5  pm) and mounted 
on 3-aminopropyltriethoxysilan-coated glass slides. Sections were depar- 
affinized by runs through xylene, ethanol, chloroform. ethanol, and were 
then air-dried. 
The sections (a) and (b) were pre-hybridized at 5O'Cfor 3 hr with 1 ml 
hybridization solution, as described by Lahr et al. (22). Subsequently, they 
were hybridized overnight at S O T  with either (a) 5 ng labeled tRNA probe 
(spec. act. 7 x los cpmlClg) or with 200 ng Dig-labeled cRNA (b) in 150 
pl hybridization solution in a humidified chamber. Controls consisted of 
sections pre-treated with 100 pg/ml RNAse A at 37% for 60 min before 
hybridization, or of sense RNA. After hybridization, sections with isotopic 
cRNA probes were washed and further treated as described. Slides were 
rinsed in ascending alcohol solutions, air-dried, and dipped in Ilford K2 
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emulsion diluted 1:1 with H20. They were exposed for 6 weeks at 4'C and 
developed with Kodak D19 at 16°C for 4 min. The sections were counter- 
stained with hemalum (Mayer) and eosin. 
After hybridization, sections with non-isotopic cRNA probes (b) were 
rinsed twice in 2 x SSC (0.3 M sodium chloride, 30 mM sodium citrate. pH 
7.0). 50% formamide for 20 min at 50'C and once in 2 x SSC at room 
temperature. To reduce background, sections were treated for 30 min at 
37'C in 2 x SSC and 100 pglml RNAse A. They were washed twice at 
room temperature in 2 x SSC and once with 2 x SSC, 50% formamide 
at 50'C for 5 min. Sections were incubated overnight in 2 x SSC, 0.084% 
saponin, 2% normal sheep serum at room temperature. Sections were washed 
twice for 10 min in Buffer 1 containing 0.1 M Tris-HCI. 0.15 NaCI (pH 
7.5) and incubated for 5 hr at room temperature in a humidified chamber 
with anti-digoxigenin-AP, Fab fragments (1:500) (Boehringer) in 1% NSS, 
0.084% saponin in Buffer 1. Sections were washed for 10 min at room tem- 
perature in Buffer 1 and for 10 min in Buffer 3 containing 0.1 M Tris-HCI. 
0.1 M NaCI, 50 mM MgC12 (pH 9.5). Sections were incubated overnight 
in a dark, humidified chamber in 0.41 mM 4-nitrobluetetrazoliumchloride 
(NBT), 0.38 mM BCIP (5-bromo-4-chloro-3-indolyl-phosphate) in Buffer 
3 (NBT and BCIP from Boehringer). Sections were washed in Buffer 4 con- 
taining 10 mM Tris-HCI. 1 mM EDTA (pH 8.0). and then covered with 
a coverslip using glycerine-gelatin. 
Results 
S1 nuclease protection analysis revealed a completely protected band 
of approximately 836 nucleotides. The size of the protected band 
(836 nt) was calculated from the rat sequence map of CGA (28). 
This result indicates the presence of mRNA co-linear to the whole 
probe covering one third of the chromogranin A mRNA at the 3' 
terminal portion in cerebellum, spinal cord, and adrenal. In con- 
trast to the high amount of CGA-specific mRNA in adrenal; the 
level of CGA-specific mRNA in cerebellum and in spinal cord was 
lower (Figure 1). 
By in situ hybridization histochemistry with isotopic and non- 
isotopic labeled anti-sense cRNA probe, we found that CGA-specific 
mRNA within the cerebellum is mainly confined to Purkinje cells 
and neurons of the deep cerebellar nuclei (Figures 2A and 2B). 
Weak labeling was also seen over the granular layer of the cerebel- 
lar cortex. In the thoracic spinal cord, cell bodies of neurons (Lam- 
inae I-X) were positive for CGA mRNA. Figure 3A shows heavily 
labeled large (alpha-) and small (gamma-) motoneurons in Lam- 
ina IX of the ventral horn. Cell bodies in Laminae 111-V of the dor- 
sal horn, heterogeneous in size, were also positive for CGA mRNA 
(Figure 3B). 
Within the cerebellum, neurons of the cerebellar nuclei and 
of Purkinje cells showed CGA-like immunoreactivity. Faint im- 
munoreaction which could not be localized to cells was seen over 
the entire cerebellar cortex (Figure 4A). In the thoracic spinal cord, 
CGA-like immunoreactivity was observed in cell bodies of the neu- 
rons of all laminae (Figure 4C). Controls did not show any CGA- 
like immunoreactivity in the Purkinje cells (Figure 4B) and in the 
cell bodies of the neurons of all laminae of the thoracic spinal cord 
(not shown). 
As determined by radioimmunoassay, the amounts of CGA in 
acid extracts of the spinal cord and the cerebellum are low and are 
comparable to the values observed in brainstem, forebrain, and 
pancreas (Table 1). By contrast, the levels of CGA (as detected by 
radioimmunoassay) in the olfactory bulb were found to be on the 
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Figure 1. S1 nuclease protection analysis of extracted mRNA of rat tissues. 
A single-stranded anti-sense DNA probe derived from rCGA M13(-) clones, 
as described by Lahr et al. (22), was used for hybridization. In Lanes 3- 
5 the 3zP-labeled cDNA served as hybridization probe for 20 pg total RNA 
each. Lane 3: adrenal medulla; Lane 4: cerebellum; Lane 5: spinal cord. As 
a size marker, Hpall digested pBR322 was applied to Lane 1. The sizes are 
indicated on the left side. The upper band of approximately 950 nt, as calcu- 
lated by the sequence published (28). in Lane 2 represents undigested probe 
containing flanking Bluescribe M13(-) vector sequences, while the protected 
band of approximately 836 nt fragment (arrow), as calculated by the sequence 
published (28). indicates rCGA mRNA in the tissues analyzed. Duration of film 
exposure was 36 hr. 
same order of magnitude as observed in the pituitary or the adrenals. 
confirming an earlier report (22). 
Discussion 
The present study analyzes for the first time the distribution of 
CGA mRNA and of CGA-like immunoreactivity in the cerebel- 
lum and the spinal cord of the rat. The data presented here indi- 
cate a high degree of homology within a stretch of approximately 
800 nucleotides around the 3' coding and non-coding region cover- 
ing Exons 6-8 between peripheral (adrenal) CGA and that of the 
central nervous system. CGA-like immunoreactivity is mainly local- 
ized in Purkinje cells of the cerebellar cortex, in neurons of the 
deep cerebellar nuclei, and in the neurons of the ventral, lateral, 
and dorsal horns of the rat spinal cord. As in other brain areas, 
CGA levels in cerebellum and spinal cord are low in contrast to 
the olfactory system, which contains CGA in amounts similar to 
those found in the adrenal gland and the adenohypophysis. 
A secretory protein such as CGA is rapidly transported away 
from the site of transcription to the endings, and therefore may 
easily escape immunochemical detection. This may explain the weak 
immunoreactivity of the perikarya of Purkinje cells, as well as the 
faint staining in the entire cerebellar cortex, which could reflect 
axonalldendritic transport of CGA. In the present study we com- 
bined determination of both CGA mRNA and the protein to de- 
tect sites of CGA production. In addition to Purkinje cells, which 
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Figure 2. Detection of CGA mRNA in situ hybridization of cerebellar tissue sec- 
tions using (A) radioactive and (B) Digll-UTP-labeled cRNA probe. (A) Pur- 
kinje cells (open arrows) and the heterogeneous group of cells in the granular 
layer contain rCGA-specific cRNA. ML. molecular layer; GL, granular layer. (B) 
Perikarya of the deep cerebellar nuclei are stained with Digll-UTP-labeled 
cRNA probe. Bars: A = 10 prn; B = 40 pm. 
could be distinguished by their localization and size, additional 
cells of the granular layer expressed CGA mRNA. Since the cells 
of this layer are Golgi cells and glial cells, the faint CGA-like im- 
munoreactivity in the entire cerebellar cortex could be due to other 
CGA-producing cell types as well as positive fiben. should 
be mentioned at this point (see Of the 
dorsal, lateral, and ventral homs of the thoracic spinal cord also 
Figure 3. Detection of CGA mRNA by situ hybridization in sections of the tho- 
racic spinal cord using radioactive cRNA probe. (A) Cell bodies in Laminae Ill-V 
of the neurons in the dorsal horn and (B) perikarya in Lamina IX of the motoneu- 
rons (alpha, arrow; gamma, open arrow) in the ventral horn are strongly labeled. 
Bars = 10 pm. 
that 
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Table 1. Levels of immunoreactive chromogranin A in rat 
endocrine and neural tissuey 
Tissue 
Chromognnin A 
nglmg protein amount n 
Relative 
Adrenal gland 
Adenohypophysis 
Olfactory bulb 
Brainstem 
Forebrain 
Cerebellum 
Spinal cord 
Pancreas 
Liver 
422.2 t 33.8 
360.8 t 95.9 
359.2 t 29.6 
94.2 t 8.4 
55.4 f 13.8 
32.1 t 4.6 
23.8 t 3.8 
48.0 f 11.8 
7.6 f 1.1 
1.00 
0.85 
0.85 
0.22 
0.13 
0.08 
0.06 
0.11 
0.02 
10 
4 
6 
6 
6 
5 
6 
6 
10 
a Amounts of CGA (mcan t SD: n. number of tissues from different malc 
animals analyzed). 
expressed CGA. Therefore, afferent sensory neurons, which pro- 
ject back to the cerebellum and reach the granular layer (c f .  36). 
might have contributed to the diffuse CGA immunoreactivity in 
this layer. 
Large species differences exist in the central parts of the CGA 
molecule, although the C- and N-terminals are very similar (c f .  
17). Because of this, immunocytochemical investigations of CGA 
must be interpreted with caution when the topology of the epi- 
tope in the protein recognized by the antiserum, is unknown. One 
example is the recent observation that a monoclonal antibody to 
an undefined domain of human CGA exclusively stained Bergmann 
glia of the rat cerebellum, whereas rabbit antibodies to bovine or 
porcine CGA d o  not (23). In this study we used an antiserum raised 
against the 16 C-terminal (Exon 8) amino acids of CGA, which 
differ only slightly in sequence in rat, cow, and human. With this 
antiserum we did not find the pattern typical for Bergmann glia. 
Furthermore, our data, which show that Purkinje cells and perikarya 
of the deep cerebellar nuclei in the rat contain CGA-like im- 
munoreactivity, are further supported by in situ hybridization 
histochemistry using cRNA probes complementary to the C-ter- 
mina1 portion of the rat CGA mRNA. In earlier studies carried 
out in the sheep brain with an antiserum against bovine CGA, it 
was observed that CGA occurs in Purkinje cells, in Golgi cells of 
the granular layer, and in neurons of the deep cerebellar nuclei 
(33). Our findings in the rat on distribution of CGA-like im- 
munoreactivity and CGA mRNA using in situ hybridization tech- 
niques support and extend these data. 
Our results show the presence of CGA-like immunoreactivity 
and its mRNA in deep cerebellar nuclei. Interestingly, there is evi- 
dence for the presence of another member of the chromogra- 
ninlsecretogranin protein family, i.e., chromogranin B, in the rat 
perikarya of deep cerebellar nuclei, since its mRNA was described 
there (11). On the other hand, these p e r k u p  were not immunoreac- 
tive for secretogranin I1 (chromogranin C), although they were sur- 
rounded by a loose network of immunoreactive fibers (6). which 
Figure 4. Immunocytochemical detection of chromogranin A in the cerebellum 
and in the thoracic spinal cord. (A) The immunoreaction is confined mainly to 
the Purkinje cells (arrows). (B) Note absence of CGA immunoreactivity of Pur- 
kinje cells (arrow) in a control section (omission of CGA antiserum). (C) CGA 
4 
immunoreactivity is confined to the neurons of the ventral horn (VH) and in the 
lateral as well as the dorsal horn (DH) in the thoracic spinal cord. Bars: A,B 
= 20 pm; C = 40 pm. 
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may at least in part present endings originating from immunoreac- 
tive cerebellar Purkinje cells. Therefore, it can be concluded from 
the data presented here and the work of other groups that in the 
rat cerebellum all known members of the chromogranin/secretogra- 
nin protein family are detectable in cerebellar Purkinje cells, whereas 
the neurons of the deep cerebellar nuclei contain chromogranin 
A and B but not secretogranin I1 (chromogranin C). On the other 
hand, the human cerebellum was negative for CGA but the Pur- 
kinje cells stained strongly for chromogranin B (31). 
It is well known that the neurons of the cerebellar nuclei pro- 
ject to the motoneurons present in the ventral horn of the spinal 
cord (cf. 36), where we found CGA and its mRNA. The present 
study shows that in the spinal cord, CGA-like immunoreactivity 
was also present in the cells of the lateral and dorsal horn. Moreover, 
these cells of the spinal cord possess specific mRNA for CGA. There- 
fore, our data support and extend immunocytochemical results in 
the spinal cord of the sheep (33) as well as in cholinergic nerve 
endings of the rat (5,35). 
As mentioned above, projections of neurons of the dorsal horn 
reach the cerebellum and might be responsible for the diffuse CGA 
immunoreactivity in the granular layer. The fact that neurons of 
all layers of the spinal cord express CGA may indicate that CGA 
is involved in both efferent and afferent signal transduction. One 
could therefore speculate that CGA may be important for motor 
control in general. 
Clearly, the function of CGA in neurons has not been exam- 
ined. However, hormone release by endocrine cells is modulated 
by CGA or its fragments (cf. 7,10,14,15,32). In addition, CGA within 
the endocrine cells is involved in sorting of hormones to the regula- 
tory pathway and in the control of intracellular calcium (20,21, 
29,30). Since the basic mechanisms underlying secretion of hor- 
mones and release of neurotransmitters are very similar, CGA may 
fulfill similar roles in neurons. 
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